Table of Content

1 Report Overview
1.1 Short Bowel Syndrome Drugs Definition
1.2 Market by Type
1.2.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral Short Bowel Syndrome Drugs
1.2.3 Tablet Short Bowel Syndrome Drugs
1.3 Market Segment by Sale Channel
1.3.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2018 VS 2022 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Short Bowel Syndrome Drugs Sales
2.1 Global Short Bowel Syndrome Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global Short Bowel Syndrome Drugs Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Short Bowel Syndrome Drugs Revenue by Region
2.3.1 Global Short Bowel Syndrome Drugs Revenue by Region (2018-2024)
2.3.2 Global Short Bowel Syndrome Drugs Revenue by Region (2024-2034)
2.4 Global Short Bowel Syndrome Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Short Bowel Syndrome Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Short Bowel Syndrome Drugs Sales Quantity by Region
2.6.1 Global Short Bowel Syndrome Drugs Sales Quantity by Region (2018-2024)
2.6.2 Global Short Bowel Syndrome Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Short Bowel Syndrome Drugs Sales Quantity by Manufacturers
3.1.1 Global Short Bowel Syndrome Drugs Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Short Bowel Syndrome Drugs Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Drugs Sales in 2022
3.2 Global Short Bowel Syndrome Drugs Revenue by Manufacturers
3.2.1 Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Drugs Revenue in 2022
3.3 Global Short Bowel Syndrome Drugs Sales Price by Manufacturers
3.4 Global Key Players of Short Bowel Syndrome Drugs, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Short Bowel Syndrome Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Short Bowel Syndrome Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Short Bowel Syndrome Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Short Bowel Syndrome Drugs Sales Quantity by Type
4.1.1 Global Short Bowel Syndrome Drugs Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Short Bowel Syndrome Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Short Bowel Syndrome Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global Short Bowel Syndrome Drugs Revenue by Type
4.2.1 Global Short Bowel Syndrome Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Short Bowel Syndrome Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Short Bowel Syndrome Drugs Price by Type
4.3.1 Global Short Bowel Syndrome Drugs Price by Type (2018-2024)
4.3.2 Global Short Bowel Syndrome Drugs Price Forecast by Type (2024-2034)
5 Market Size by Sale Channel
5.1 Global Short Bowel Syndrome Drugs Sales Quantity by Sale Channel
5.1.1 Global Short Bowel Syndrome Drugs Historical Sales Quantity by Sale Channel (2018-2024)
5.1.2 Global Short Bowel Syndrome Drugs Forecasted Sales Quantity by Sale Channel (2024-2034)
5.1.3 Global Short Bowel Syndrome Drugs Sales Quantity Market Share by Sale Channel (2018-2034)
5.2 Global Short Bowel Syndrome Drugs Revenue by Sale Channel
5.2.1 Global Short Bowel Syndrome Drugs Historical Revenue by Sale Channel (2018-2024)
5.2.2 Global Short Bowel Syndrome Drugs Forecasted Revenue by Sale Channel (2024-2034)
5.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2018-2034)
5.3 Global Short Bowel Syndrome Drugs Price by Sale Channel
5.3.1 Global Short Bowel Syndrome Drugs Price by Sale Channel (2018-2024)
5.3.2 Global Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2024-2034)
6 North America
6.1 North America Short Bowel Syndrome Drugs Sales by Company
6.1.1 North America Short Bowel Syndrome Drugs Revenue by Company (2018-2024)
6.1.2 North America Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024)
6.2 North America Short Bowel Syndrome Drugs Market Size by Type
6.2.1 North America Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America Short Bowel Syndrome Drugs Revenue by Type (2018-2034)
6.3 North America Short Bowel Syndrome Drugs Market Size by Sale Channel
6.3.1 North America Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2034)
6.3.2 North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2034)
6.4 North America Short Bowel Syndrome Drugs Market Size by Country
6.4.1 North America Short Bowel Syndrome Drugs Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Short Bowel Syndrome Drugs Revenue by Country (2018-2034)
6.4.3 North America Short Bowel Syndrome Drugs Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Short Bowel Syndrome Drugs Sales by Company
7.1.1 Europe Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024)
7.1.2 Europe Short Bowel Syndrome Drugs Revenue by Company (2018-2024)
7.2 Europe Short Bowel Syndrome Drugs Market Size by Type
7.2.1 Europe Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe Short Bowel Syndrome Drugs Revenue by Type (2018-2034)
7.3 Europe Short Bowel Syndrome Drugs Market Size by Sale Channel
7.3.1 Europe Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2034)
7.3.2 Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2034)
7.4 Europe Short Bowel Syndrome Drugs Market Size by Country
7.4.1 Europe Short Bowel Syndrome Drugs Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Short Bowel Syndrome Drugs Revenue by Country (2018-2034)
7.4.3 Europe Short Bowel Syndrome Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Short Bowel Syndrome Drugs Sales by Company
8.1.1 China Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024)
8.1.2 China Short Bowel Syndrome Drugs Revenue by Company (2018-2024)
8.2 China Short Bowel Syndrome Drugs Market Size by Type
8.2.1 China Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2034)
8.2.2 China Short Bowel Syndrome Drugs Revenue by Type (2018-2034)
8.3 China Short Bowel Syndrome Drugs Market Size by Sale Channel
8.3.1 China Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2034)
8.3.2 China Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2034)
9 APAC (excluding China)
9.1 APAC Short Bowel Syndrome Drugs Sales by Company
9.1.1 APAC Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024)
9.1.2 APAC Short Bowel Syndrome Drugs Revenue by Company (2018-2024)
9.2 APAC Short Bowel Syndrome Drugs Market Size by Type
9.2.1 APAC Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC Short Bowel Syndrome Drugs Revenue by Type (2018-2034)
9.3 APAC Short Bowel Syndrome Drugs Market Size by Sale Channel
9.3.1 APAC Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2034)
9.3.2 APAC Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2034)
9.4 APAC Short Bowel Syndrome Drugs Market Size by Region
9.4.1 APAC Short Bowel Syndrome Drugs Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Short Bowel Syndrome Drugs Revenue by Region (2018-2034)
9.4.3 APAC Short Bowel Syndrome Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Market Size by Sale Channel
10.3.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2034)
10.3.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2034)
10.4 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Information
11.1.2 Emmaus Medical Overview
11.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Emmaus Medical Short Bowel Syndrome Drugs Products and Services
11.1.5 Emmaus Medical Short Bowel Syndrome Drugs SWOT Analysis
11.1.6 Emmaus Medical Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck Short Bowel Syndrome Drugs Products and Services
11.2.5 Merck Short Bowel Syndrome Drugs SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Overview
11.3.3 Takeda Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Takeda Short Bowel Syndrome Drugs Products and Services
11.3.5 Takeda Short Bowel Syndrome Drugs SWOT Analysis
11.3.6 Takeda Recent Developments
11.4 Ardelyx
11.4.1 Ardelyx Company Information
11.4.2 Ardelyx Overview
11.4.3 Ardelyx Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Ardelyx Short Bowel Syndrome Drugs Products and Services
11.4.5 Ardelyx Short Bowel Syndrome Drugs SWOT Analysis
11.4.6 Ardelyx Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Information
11.5.2 Naia Pharmaceuticals Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Products and Services
11.5.5 Naia Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
11.5.6 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Company Information
11.6.2 Nutrinia Overview
11.6.3 Nutrinia Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Nutrinia Short Bowel Syndrome Drugs Products and Services
11.6.5 Nutrinia Short Bowel Syndrome Drugs SWOT Analysis
11.6.6 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Company Information
11.7.2 OxThera Overview
11.7.3 OxThera Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 OxThera Short Bowel Syndrome Drugs Products and Services
11.7.5 OxThera Short Bowel Syndrome Drugs SWOT Analysis
11.7.6 OxThera Recent Developments
11.8 GLyPharma Therapeutic
11.8.1 GLyPharma Therapeutic Company Information
11.8.2 GLyPharma Therapeutic Overview
11.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Products and Services
11.8.5 GLyPharma Therapeutic Short Bowel Syndrome Drugs SWOT Analysis
11.8.6 GLyPharma Therapeutic Recent Developments
11.9 Sancilio Pharmaceuticals
11.9.1 Sancilio Pharmaceuticals Company Information
11.9.2 Sancilio Pharmaceuticals Overview
11.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Products and Services
11.9.5 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
11.9.6 Sancilio Pharmaceuticals Recent Developments
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Information
11.10.2 Zealand Pharma Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Zealand Pharma Short Bowel Syndrome Drugs Products and Services
11.10.5 Zealand Pharma Short Bowel Syndrome Drugs SWOT Analysis
11.10.6 Zealand Pharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Short Bowel Syndrome Drugs Value Chain Analysis
12.2 Short Bowel Syndrome Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Short Bowel Syndrome Drugs Production Mode & Process
12.4 Short Bowel Syndrome Drugs Sales and Marketing
12.4.1 Short Bowel Syndrome Drugs Sales Channels
12.4.2 Short Bowel Syndrome Drugs Distributors
12.5 Short Bowel Syndrome Drugs Customers
13 Market Dynamics
13.1 Short Bowel Syndrome Drugs Industry Trends
13.2 Short Bowel Syndrome Drugs Market Drivers
13.3 Short Bowel Syndrome Drugs Market Challenges
13.4 Short Bowel Syndrome Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Short Bowel Syndrome Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oral Short Bowel Syndrome Drugs
Table 3. Major Manufacturers of Tablet Short Bowel Syndrome Drugs
Table 4. Global Short Bowel Syndrome Drugs Market Size Growth Rate (CAGR) by Sale Channel, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Short Bowel Syndrome Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Short Bowel Syndrome Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2018-2024)
Table 8. Global Short Bowel Syndrome Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2024-2034)
Table 10. Global Short Bowel Syndrome Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Pcs)
Table 11. Global Short Bowel Syndrome Drugs Sales by Region (2018-2024) & (K Pcs)
Table 12. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2018-2024)
Table 13. Global Short Bowel Syndrome Drugs Sales by Region (2024-2034) & (K Pcs)
Table 14. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2024-2034)
Table 15. Global Short Bowel Syndrome Drugs Sales Quantity by Manufacturers (2018-2024) & (K Pcs)
Table 16. Global Short Bowel Syndrome Drugs Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Short Bowel Syndrome Drugs Price by Manufacturers 2018-2024 (USD/Pcs)
Table 20. Global Key Players of Short Bowel Syndrome Drugs, Industry Ranking, 2021 VS 2022
Table 21. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome Drugs as of 2022)
Table 23. Global Key Manufacturers of Short Bowel Syndrome Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Short Bowel Syndrome Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Short Bowel Syndrome Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2024) & (K Pcs)
Table 28. Global Short Bowel Syndrome Drugs Sales Quantity by Type (2024-2034) & (K Pcs)
Table 29. Global Short Bowel Syndrome Drugs Sales Quantity Share by Type (2018-2024)
Table 30. Global Short Bowel Syndrome Drugs Sales Quantity Share by Type (2024-2034)
Table 31. Global Short Bowel Syndrome Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Short Bowel Syndrome Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Short Bowel Syndrome Drugs Revenue Share by Type (2018-2024)
Table 34. Global Short Bowel Syndrome Drugs Revenue Share by Type (2024-2034)
Table 35. Short Bowel Syndrome Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 36. Global Short Bowel Syndrome Drugs Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 37. Global Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2024) & (K Pcs)
Table 38. Global Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2024-2034) & (K Pcs)
Table 39. Global Short Bowel Syndrome Drugs Sales Quantity Share by Sale Channel (2018-2024)
Table 40. Global Short Bowel Syndrome Drugs Sales Quantity Share by Sale Channel (2024-2034)
Table 41. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2024) & (US$ Million)
Table 42. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2024-2034) & (US$ Million)
Table 43. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2018-2024)
Table 44. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2024-2034)
Table 45. Short Bowel Syndrome Drugs Price by Sale Channel (2018-2024) & (USD/Pcs)
Table 46. Global Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2024-2034) & (USD/Pcs)
Table 47. North America Short Bowel Syndrome Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024) & (K Pcs)
Table 49. North America Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2024) & (K Pcs)
Table 50. North America Short Bowel Syndrome Drugs Sales Quantity by Type (2024-2034) & (K Pcs)
Table 51. North America Short Bowel Syndrome Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Short Bowel Syndrome Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2024) & (K Pcs)
Table 54. North America Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2024-2034) & (K Pcs)
Table 55. North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2024) & (US$ Million)
Table 56. North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2024-2034) & (US$ Million)
Table 57. North America Short Bowel Syndrome Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Short Bowel Syndrome Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Short Bowel Syndrome Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Short Bowel Syndrome Drugs Sales Quantity by Country (2018-2024) & (K Pcs)
Table 61. North America Short Bowel Syndrome Drugs Sales Quantity by Country (2024-2034) & (K Pcs)
Table 62. Europe Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024) & (K Pcs)
Table 63. Europe Short Bowel Syndrome Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2024) & (K Pcs)
Table 65. Europe Short Bowel Syndrome Drugs Sales Quantity by Type (2024-2034) & (K Pcs)
Table 66. Europe Short Bowel Syndrome Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Short Bowel Syndrome Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2024) & (K Pcs)
Table 69. Europe Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2024-2034) & (K Pcs)
Table 70. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2024) & (US$ Million)
Table 71. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2024-2034) & (US$ Million)
Table 72. Europe Short Bowel Syndrome Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Short Bowel Syndrome Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Short Bowel Syndrome Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Short Bowel Syndrome Drugs Sales Quantity by Country (2018-2024) & (K Pcs)
Table 76. Europe Short Bowel Syndrome Drugs Sales Quantity by Country (2024-2034) & (K Pcs)
Table 77. China Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024) & (K Pcs)
Table 78. China Short Bowel Syndrome Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2024) & (K Pcs)
Table 80. China Short Bowel Syndrome Drugs Sales Quantity by Type (2024-2034) & (K Pcs)
Table 81. China Short Bowel Syndrome Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Short Bowel Syndrome Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2024) & (K Pcs)
Table 84. China Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2024-2034) & (K Pcs)
Table 85. China Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2024) & (US$ Million)
Table 86. China Short Bowel Syndrome Drugs Revenue by Sale Channel (2024-2034) & (US$ Million)
Table 87. APAC Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024) & (K Pcs)
Table 88. APAC Short Bowel Syndrome Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2024) & (K Pcs)
Table 90. APAC Short Bowel Syndrome Drugs Sales Quantity by Type (2024-2034) & (K Pcs)
Table 91. APAC Short Bowel Syndrome Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Short Bowel Syndrome Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2024) & (K Pcs)
Table 94. APAC Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2024-2034) & (K Pcs)
Table 95. APAC Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2024) & (US$ Million)
Table 96. APAC Short Bowel Syndrome Drugs Revenue by Sale Channel (2024-2034) & (US$ Million)
Table 97. APAC Short Bowel Syndrome Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Short Bowel Syndrome Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Short Bowel Syndrome Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Short Bowel Syndrome Drugs Sales Quantity by Region (2018-2024) & (K Pcs)
Table 101. APAC Short Bowel Syndrome Drugs Sales Quantity by Region (2024-2034) & (K Pcs)
Table 102. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Company (2018-2024) & (K Pcs)
Table 103. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Type (2018-2024) & (K Pcs)
Table 105. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Type (2024-2034) & (K Pcs)
Table 106. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2018-2024) & (K Pcs)
Table 109. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Sale Channel (2024-2034) & (K Pcs)
Table 110. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Country (2018-2024) & (K Pcs)
Table 116. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity by Country (2024-2034) & (K Pcs)
Table 117. Emmaus Medical Company Information
Table 118. Emmaus Medical Description and Overview
Table 119. Emmaus Medical Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Emmaus Medical Short Bowel Syndrome Drugs Product and Services
Table 121. Emmaus Medical Short Bowel Syndrome Drugs SWOT Analysis
Table 122. Emmaus Medical Recent Developments
Table 123. Merck Company Information
Table 124. Merck Description and Overview
Table 125. Merck Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 126. Merck Short Bowel Syndrome Drugs Product and Services
Table 127. Merck Short Bowel Syndrome Drugs SWOT Analysis
Table 128. Merck Recent Developments
Table 129. Takeda Company Information
Table 130. Takeda Description and Overview
Table 131. Takeda Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Takeda Short Bowel Syndrome Drugs Product and Services
Table 133. Takeda Short Bowel Syndrome Drugs SWOT Analysis
Table 134. Takeda Recent Developments
Table 135. Ardelyx Company Information
Table 136. Ardelyx Description and Overview
Table 137. Ardelyx Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Ardelyx Short Bowel Syndrome Drugs Product and Services
Table 139. Ardelyx Short Bowel Syndrome Drugs SWOT Analysis
Table 140. Ardelyx Recent Developments
Table 141. Naia Pharmaceuticals Company Information
Table 142. Naia Pharmaceuticals Description and Overview
Table 143. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product and Services
Table 145. Naia Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
Table 146. Naia Pharmaceuticals Recent Developments
Table 147. Nutrinia Company Information
Table 148. Nutrinia Description and Overview
Table 149. Nutrinia Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Nutrinia Short Bowel Syndrome Drugs Product and Services
Table 151. Nutrinia Short Bowel Syndrome Drugs SWOT Analysis
Table 152. Nutrinia Recent Developments
Table 153. OxThera Company Information
Table 154. OxThera Description and Overview
Table 155. OxThera Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 156. OxThera Short Bowel Syndrome Drugs Product and Services
Table 157. OxThera Short Bowel Syndrome Drugs SWOT Analysis
Table 158. OxThera Recent Developments
Table 159. GLyPharma Therapeutic Company Information
Table 160. GLyPharma Therapeutic Description and Overview
Table 161. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 162. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product and Services
Table 163. GLyPharma Therapeutic Short Bowel Syndrome Drugs SWOT Analysis
Table 164. GLyPharma Therapeutic Recent Developments
Table 165. Sancilio Pharmaceuticals Company Information
Table 166. Sancilio Pharmaceuticals Description and Overview
Table 167. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product and Services
Table 169. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs SWOT Analysis
Table 170. Sancilio Pharmaceuticals Recent Developments
Table 171. Zealand Pharma Company Information
Table 172. Zealand Pharma Description and Overview
Table 173. Zealand Pharma Short Bowel Syndrome Drugs Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 174. Zealand Pharma Short Bowel Syndrome Drugs Product and Services
Table 175. Zealand Pharma Short Bowel Syndrome Drugs SWOT Analysis
Table 176. Zealand Pharma Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Short Bowel Syndrome Drugs Distributors List
Table 180. Short Bowel Syndrome Drugs Customers List
Table 181. Short Bowel Syndrome Drugs Market Trends
Table 182. Short Bowel Syndrome Drugs Market Drivers
Table 183. Short Bowel Syndrome Drugs Market Challenges
Table 184. Short Bowel Syndrome Drugs Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome Drugs Product Picture
Figure 2. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Short Bowel Syndrome Drugs Market Share by Type in 2022 & 2034
Figure 4. Oral Short Bowel Syndrome Drugs Product Picture
Figure 5. Tablet Short Bowel Syndrome Drugs Product Picture
Figure 6. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Short Bowel Syndrome Drugs Market Share by Sale Channel in 2022 & 2034
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Short Bowel Syndrome Drugs Report Years Considered
Figure 12. Global Short Bowel Syndrome Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Short Bowel Syndrome Drugs Revenue 2018-2034 (US$ Million)
Figure 14. Global Short Bowel Syndrome Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Short Bowel Syndrome Drugs Sales Quantity 2018-2034 (K Pcs)
Figure 16. Global Short Bowel Syndrome Drugs Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Short Bowel Syndrome Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Short Bowel Syndrome Drugs Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 19. North America Short Bowel Syndrome Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Short Bowel Syndrome Drugs Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 21. Europe Short Bowel Syndrome Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Short Bowel Syndrome Drugs Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. China Short Bowel Syndrome Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Short Bowel Syndrome Drugs Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. APAC Short Bowel Syndrome Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Short Bowel Syndrome Drugs Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Short Bowel Syndrome Drugs Revenue in 2022
Figure 30. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Short Bowel Syndrome Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2018-2034)
Figure 33. Global Short Bowel Syndrome Drugs Sales Quantity Market Share by Sale Channel (2018-2034)
Figure 34. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2018-2034)
Figure 35. North America Short Bowel Syndrome Drugs Revenue Market Share by Company in 2022
Figure 36. North America Short Bowel Syndrome Drugs Sales Quantity Market Share by Company in 2022
Figure 37. North America Short Bowel Syndrome Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Short Bowel Syndrome Drugs Revenue Market Share by Type (2018-2034)
Figure 39. North America Short Bowel Syndrome Drugs Sales Quantity Market Share by Sale Channel (2018-2034)
Figure 40. North America Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2018-2034)
Figure 41. North America Short Bowel Syndrome Drugs Revenue Share by Country (2018-2034)
Figure 42. North America Short Bowel Syndrome Drugs Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Short Bowel Syndrome Drugs Sales Quantity Market Share by Company in 2022
Figure 46. Europe Short Bowel Syndrome Drugs Revenue Market Share by Company in 2022
Figure 47. Europe Short Bowel Syndrome Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Short Bowel Syndrome Drugs Revenue Market Share by Type (2018-2034)
Figure 49. Europe Short Bowel Syndrome Drugs Sales Quantity Market Share by Sale Channel (2018-2034)
Figure 50. Europe Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2018-2034)
Figure 51. Europe Short Bowel Syndrome Drugs Revenue Share by Country (2018-2034)
Figure 52. Europe Short Bowel Syndrome Drugs Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 54. France Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 58. China Short Bowel Syndrome Drugs Sales Quantity Market Share by Company in 2022
Figure 59. China Short Bowel Syndrome Drugs Revenue Market Share by Company in 2022
Figure 60. China Short Bowel Syndrome Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Short Bowel Syndrome Drugs Revenue Market Share by Type (2018-2034)
Figure 62. China Short Bowel Syndrome Drugs Sales Quantity Market Share by Sale Channel (2018-2034)
Figure 63. China Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2018-2034)
Figure 64. APAC Short Bowel Syndrome Drugs Sales Quantity Market Share by Company in 2022
Figure 65. APAC Short Bowel Syndrome Drugs Revenue Market Share by Company in 2022
Figure 66. APAC Short Bowel Syndrome Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Short Bowel Syndrome Drugs Revenue Market Share by Type (2018-2034)
Figure 68. APAC Short Bowel Syndrome Drugs Sales Quantity Market Share by Sale Channel (2018-2034)
Figure 69. APAC Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2018-2034)
Figure 70. APAC Short Bowel Syndrome Drugs Revenue Share by Region (2018-2034)
Figure 71. APAC Short Bowel Syndrome Drugs Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 76. India Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity Market Share by Sale Channel (2018-2034)
Figure 82. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2018-2034)
Figure 83. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Share by Country (2018-2034)
Figure 85. Brazil Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Short Bowel Syndrome Drugs Revenue (2018-2034) & (US$ Million)
Figure 90. Short Bowel Syndrome Drugs Value Chain
Figure 91. Short Bowel Syndrome Drugs Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed